<- Back to digest

JAAOS - 2026-10-29 - Journal Article

Association of Preoperative Psychiatric Medication Use With Complication Rates After Total Ankle Arthroplasty.

Martino JA, Pottanat P, Cave S, Hashioka H, Chao M, Gross CE, Scott DJ

retrospective cohortLOE IIIn = 2,328 (1,164 per propensity-matched cohort)Mean ~828 days (psychiatric cohort), ~790 days (control); range 730–1,095 days

Topics

trauma
PMID: 42954460DOI: 10.5435/JAAOS-D-26-00140View on PubMed ->

Key Takeaway

Preoperative psychiatric medication use is associated with an 8.6% higher absolute risk of mechanical loosening at 2 years after total ankle arthroplasty (RD = 0.086, p < 0.001).

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study used the TriNetX database (2005–2023) to determine whether preoperative psychiatric medication use within 1 year of surgery affects complication rates after TAA, comparing 1,164 propensity-matched pairs. At 2 years, the psychiatric medication cohort had significantly higher rates of mechanical loosening (RD=0.086), implant-related pain (RD=0.021), and periprosthetic fracture (RD=0.009); at 6 months, acute respiratory failure was more common in the psychiatric cohort while wound dehiscence was paradoxically more frequent in controls.

Key Limitation

The TriNetX database cannot distinguish between psychiatric drug classes (e.g., SSRIs vs. antipsychotics vs. mood stabilizers), making it impossible to determine which medications drive the observed implant failure risk or to adjust surgical decision-making at the drug-specific level.

Original Abstract

BACKGROUND

Psychiatric medications are widely used in the United States, yet their effect on outcomes in patients undergoing total ankle arthroplasty (TAA) remains unclear. The purpose of this study was to determine the effect of preoperative psychiatric medication use on postoperative medical and surgical complications after TAA.

METHODS

The TriNetX database (2005 to 2023) was queried to retrospectively identify patients who underwent TAA. Patients were stratified into two cohorts: one with preoperative psychiatric medication use within 1 year before operation (C1) and one without preoperative psychiatric medication use (C2). Propensity score matching was conducted using a 1:1 ratio to control for demographics and comorbidities. After matching, the psychiatry medication cohort consisted of 1,164 patients ,of whom 42.8% were female, with a mean age of 58.9 years, body mass index (BMI) of 30.8 kg/m2, and follow-up duration of 828.0 days (range, 730 to 1,095 days). The control cohort consisted of 1,164 patients, of whom 40.9% were female, with a mean age of 59.0 years, BMI of 30.5 kg/m2, and follow-up duration of 790.5 days (range, 730 to 1,095 days).

RESULTS

At 6 months, patients in the psychiatric medication cohort had a significantly higher risk of acute respiratory failure compared with control subjects (risk differences [RD] = 0.009; 95% confidence intervals [CI], 0.003 to 0.014; P = 0.002). Conversely, treatment for wound dehiscence was more frequent among control subjects (RD = -0.009; 95% CI, -0.014 to -0.003; P = 0.002). At 2 years, the psychiatric medication cohort demonstrated higher risks of mechanical loosening (RD = 0.086; 95% CI, 0.060 to 0.112; P < 0.001), implant-related pain (RD = 0.021; 95% CI, 0.005 to 0.036; P = 0.008), and periprosthetic fracture (RD = 0.009; 95% CI, 0.003 to 0.014; P = 0.002).

CONCLUSION

Preoperative psychiatric medication use is associated with markedly higher rates of long-term implant-related complications after TAA. Additional research is needed to elucidate mechanisms underlying these associations.

LEVEL OF EVIDENCE

Level III, Retrospective Cohort Study.